This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients | MicrobiomeTrials
← Back to trials NCT04038619
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2021-02-01Est. Completion: 2027-12-31
Enrollment target: 40 participantsLocations M D Anderson Cancer Center, Houston, Texas, United States Other microbiome trials you might be interested in Ulcerative Colitis
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-a…
New York, United States Est. completion Jun 23, 2027
Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United States Est. completion Jun 1, 2036
Recruiting
Ulcerative Colitis Crohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United States Est. completion Dec 15, 2026